AzTrials
AzTrials

VasectomyNCT07055178

Perioperative Virtual Reality Intervention for Pain and Anxiety During Vasectomies

A study testing Virtual reality (VR) guided meditation therapy and Treatment as usual in people with Vasectomy and Pain, run by University of Manitoba at 1 site in Canada.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if a virtual reality (VR) program (TRIPP) can reduce pain, anxiety, and distress in adult men (aged 18+) undergoing a vasectomy under local anesthesia. Read more about this study

Who is it for?
Ages 18 years and older, men onlyHealthy volunteers can take part
Conditions the study is for
Vasectomy, Pain, Anxiety
What is being tested?
Virtual reality (VR) guided meditation therapy and Treatment as usual
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteCanada
Study dates
2 Jul 2025to Aug 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Men only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 18 years of age or older.
  • Can speak and read English.
  • Have elected for a vasectomy.
  • Are scheduled to undergo their vasectomy under local anesthesia at the Men's Health Clinic

Who cannot join

  • Those who are not competent to provide informed consent (e.g., due to cognitive impairment).
  • Those who are unable to participate in a VR intervention (e.g., due to visual or auditory impairment).

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Renée El-Gabalawy, MA, PhD, C.Psych. contact

204-787-4083

renee.el-gabalawy@umanitoba.ca

Ahmed M Zalam, B.Sc. contact

204-880-6564

zalama@myumanitoba.ca

Canada1 site, 1 recruiting
  • Manitoba Men's Health Clinic

    Winnipeg, Manitoba, R3P 2S8

    Premal Patel, MD, FRCSC, 204-221-4476, ppatel5@hsc.mb.ca

    Ahmed M Zalam, B.Sc., 204-880-6564, zalama@myumanitoba.ca

    Recruiting

Other trials in Canada

About this study

Official title: A Perioperative Virtual Reality Intervention for Pain and Anxiety Management During Vasectomies: A Randomized Controlled Trial

The goal of this clinical trial is to learn if a virtual reality (VR) program (TRIPP) can reduce pain, anxiety, and distress in adult men (aged 18+) undergoing a vasectomy under local anesthesia. The main questions it aims to answer are:

  • Does using VR during a vasectomy lower patients' pain during the procedure compared to standard care?
  • Does VR reduce anxiety and distress compared to standard care?
  • Are patients more satisfied with their experience when using VR compared to standard care?
Read more

Researchers will compare two groups:

  • VR group: Patients will use a VR headset with a guided meditation program (TRIPP) during their vasectomy.
  • Control group: Patients will receive standard care (no VR).

Participants will:

  • Be randomly assigned to either the VR group or control group.
  • Complete brief questionnaires before, during, and after the procedure (about 15-20 minutes each time).
  • (VR group only) Use a VR headset during the procedure and provide optional feedback about the experience.

Why is this important? Vasectomies are typically done with local anesthesia (pain relief), but many patients still feel anxiety or discomfort. VR may help distract and relax patients, improving their experience. This study will help health professionals understand if VR could be a useful option for future patients.

Being tested
Virtual reality (VR) guided meditation therapy, Treatment as usual
Keywords
Virtual Reality, TRIPP, Vasectomy
Medical subject headings
Pain, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual reality (VR) guided meditation therapyDevice

    Participants will engage in the TRIPP relaxation app on the MetaQuest 3 VR headset.

  • Treatment as usualOther

    Participants undergo a standard vasectomy.

Study groups in NCT07055178
Study groupRoleWhat they receive
Standard VasectomyActive comparatorVasectomy treatment as usual, with local anesthetic, without virtual reality.
Receives: Other: Treatment as usual
Virtual Reality VasectomyExperimentalThis group of participants will receive undergo their vasectomy with the virtual reality intervention alongside the local anesthetic.
Receives: Device: Virtual reality (VR) guided meditation therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Numeric Rating Scale (NRS) for Pain Severity

    During and immediately following the procedure, patients will be momentarily interrupted to give a brief NRS verbal response question measure of their level of acute pain, this is on a scale of 0-10; 10 = most severe pain.

    Measured: Perioperatively (midway through procedure) and immediately following the procedure.

Secondary outcomes (8)
  1. Numeric Rating Scale (NRS) for Discomfort Severity

    During and immediately following the procedure, patients will be momentarily interrupted to give a brief NRS verbal response question measure of their level of acute discomfort, this is on a scale of 0-10; 10 = most severe pain.

    Measured: Perioperatively (midway through procedure) and immediately following the procedure.

  2. Numeric Rating Scale (NRS) for Anxiety Severity

    During and immediately following the procedure, patients will be momentarily interrupted to give a brief NRS verbal response question measure of their level of acute anxiety, this is on a scale of 0-10; 10 = most severe pain.

    Measured: Perioperatively (midway through procedure) and immediately following the procedure.

  3. PROMIS Pain Intensity Scale Total Score

    Immediately following the procedure, patients will be asked to respond to a short verbal Patient-Reported Outcomes Measurement Information System (PROMIS) pain intensity questionnaire with questions surrounding experienced pain (scored 3 - 15 ; 15 = greatest pain severity).

    Measured: Within 10 minutes postoperatively (in the recovery room)

  4. State Trait Anxiety Inventory Total Score

    Brief self-report questionnaire with questions surrounding anxiety traits (scale 0-63 ; 63 = most severe anxiety)

    Measured: 10 minutes preoperatively (baseline) and within 10 minutes postoperatively (in the recovery room.

  5. National Comprehensive Cancer Network (NCCN) Anxiety Thermometer Score (adapted from Distress Thermometer)

    Brief self-report visual analogue scale (VAS) for anxiety. Scored from 0-10 ; 10 = extreme anxiety.

    Measured: 10 minutes preoperatively (baseline) and within 10 minutes postoperatively (in the recovery room.

  6. Satisfaction with Surgery

    Brief self-report item to assess overall satisfaction with their procedure. Scaled from 0-10 ; 10 = greatest satisfaction.

    Measured: Within 10 minutes postoperatively (in the recovery room).

  7. iGroup Presence Questionnaire (IPQ) Score

    Brief self-report questionnaire with several questions surrounding VR experience (spatial presence, involvement, and experience realism). Each question is scored independently on a 7-point Likert scale (from -3 to +3).

    Measured: Within 10 minutes postoperatively (in the recovery room).

  8. Virtual Reality Impressions Scale

    Brief self-report questionnaire with several questions surrounding the virtual reality program experience (spatial presence, involvement, and experience realism). Each question is scored independently on a 0 - 10 scale ; 0 = complete disagreement, 10 = complete agreement.

    Measured: Within 10 minutes postoperatively (in the recovery room).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jul 2025
  2. Study start2 Jul 2025
  3. Primary completionAug 2026 (estimated)
  4. Study completionAug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07055178
Sponsor's protocol ID
HS26972
Status last verified
Jul 2025
First submitted
13 Jun 2025
Last updated
5 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Study data and information from the study will not be sent outside of the University of Manitoba. Records containing health related information will be treated as confidential in accordance with Personal Health Information Act of Manitoba (PHIA). Information gathered in this research study may be published or presented in public forums, however names and other identifying personal information will not be revealed. Data will be coded and names will not be released.

Questions about this trial

What is this clinical trial studying?

A study testing Virtual reality (VR) guided meditation therapy and Treatment as usual in people with Vasectomy and Pain, run by University of Manitoba at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 5 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Renée El-Gabalawy, MA, PhD, C.Psych. (204-787-4083, renee.el-gabalawy@umanitoba.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Numeric Rating Scale (NRS) for Pain Severity (time frame: Perioperatively (midway through procedure) and immediately following the procedure.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in